BASF CONSTRUCTION SOLUTIONS GMBH – Trademark Portfolio

Entity Type: 03

BASF CONSTRUCTION SOLUTIONS GMBH holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include MELVIS, POLYVIS, and CASTAMENT. The owner is based in D-83308 TROSTBERG.

DR. ALBERT-FRANK-STR. 32

D-83308 TROSTBERG , DE

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HYCON
HYCON
Other 2014
CASTAMENT
CASTAMENT
Registered 1999
MELVIS
MELVIS
Registered 1995
POLYVIS
POLYVIS
Registered 1995

Trademark Classifications

BASF CONSTRUCTION SOLUTIONS GMBH's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does BASF CONSTRUCTION SOLUTIONS GMBH have?

BASF CONSTRUCTION SOLUTIONS GMBH has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does BASF CONSTRUCTION SOLUTIONS GMBH file in?

BASF CONSTRUCTION SOLUTIONS GMBH files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are BASF CONSTRUCTION SOLUTIONS GMBH's most well-known trademarks?

BASF CONSTRUCTION SOLUTIONS GMBH's registered trademark portfolio includes well-known marks such as MELVIS, POLYVIS, and CASTAMENT. These are among 3 currently registered trademarks in the portfolio.

What is BASF CONSTRUCTION SOLUTIONS GMBH's trademark registration success rate?

BASF CONSTRUCTION SOLUTIONS GMBH has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.